Antioxidant and anti-diabetic potential of Passiflora alata Curtis aqueous leaves extract in type 1 diabetes mellitus (NOD-mice)

被引:36
|
作者
Colomeu, T. C. [1 ]
Figueiredo, D. [1 ]
Cazarin, C. B. B. [2 ]
Schumacher, N. S. G. [1 ]
Marostica, M. R., Jr. [2 ]
Meletti, L. M. M. [3 ]
Zollner, R. L. [1 ]
机构
[1] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, BR-13083887 Campinas, SP, Brazil
[2] Univ Estadual Campinas, Sch Food Engn, Dept Food & Nutr, BR-13083862 Campinas, SP, Brazil
[3] Agron Inst Campinas, BR-13012970 Campinas, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Antioxidant capacity; Passiflora alata Curtis; Glutathione (GSH); Type 1 Diabetes mellitus; Non-obese diabetic mice; PROINFLAMMATORY CYTOKINES; OXIDATIVE STRESS; END-PRODUCTS; EXPRESSION; CONSTITUENTS; POLYPHENOLS; RECEPTOR; ASSAYS;
D O I
10.1016/j.intimp.2013.11.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Leaves of Passiflora alata Curtis were characterized for their antioxidant capacity. Antioxidant analyses of DPPH, FRAP, ABTS, ORAC and phenolic compounds were made in three different extracts: aqueous, methanol/acetone and ethanol. Aqueous extract was found to be the best solvent for recovery of phenolic compounds and antioxidant activity, when compared with methanol/acetone and ethanol. To study the anti-inflammatory properties of this extract in experimental type 1 diabetes, NOD mice were divided into two groups: the P. alata group, treated with aqueous extract of P. alata Curtis, and a non-treated control group, followed by diabetes expression analysis. The consumption of aqueous extract and water ad libitum lasted 28 weeks. The treated-group presented a decrease in diabetes incidence, a low quantity of infiltrative cells in pancreatic islets and increased glutathione in the kidney and liver (p <0.05), when compared with the diabetic and non-diabetic control-groups. In conclusion, our results suggest that the consumption of aqueous extract of P. alata may be considered a good source of natural antioxidants and compounds found in its composition can act as anti-inflammatory agents, helping in the control of diabetes. (C) 2013 Elsevier B.V. All tights reserved.
引用
收藏
页码:106 / 115
页数:10
相关论文
共 47 条
  • [41] Age-related deregulation of Aire and peripheral tissue antigen genes in the thymic stroma of non-obese diabetic (NOD) mice is associated with autoimmune type 1 diabetes mellitus (DM-1)
    Thaís A. Fornari
    Paula B. Donate
    Claudia Macedo
    Márcia M. C. Marques
    Danielle A. Magalhães
    Geraldo A. S. Passos
    [J]. Molecular and Cellular Biochemistry, 2010, 342 : 21 - 28
  • [42] Oligonucleotide IMT504 Improves Glucose Metabolism and Controls Immune Cell Mediators in Female Diabetic NOD Mice IMT504, a Potential Therapy for Type 1 Diabetes
    Bianchi, Stefania
    Martinez Allo, Veronica C.
    Massimino, Milena
    Lavignolle Heguy, Maria del R.
    Borzone, Francisco R.
    Gomez Bustillo, Sofia
    Chasseing, Norma A.
    Libertun, Carlos
    Montaner, Alejandro D.
    Rabinovich, Gabriel A.
    Toscano, Marta A.
    Lux-Lantos, Victoria A.
    Bianchi, Maria S.
    [J]. NUCLEIC ACID THERAPEUTICS, 2021, 31 (02) : 155 - 171
  • [43] A Model-Based Approach to Predict Longitudinal HbA1c, Using Early Phase Glucose Data From Type 2 Diabetes Mellitus Patients After Anti-Diabetic Treatment
    Kjellsson, Maria C.
    Cosson, Valerie F.
    Mazer, Norman A.
    Frey, Nicolas
    Karlsson, Mats O.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (06): : 589 - 600
  • [44] The Relation of Changes in Prescribing Patterns of Anti-diabetic Drugs and HbA(1c) Levels Among Patients with Type 2 Diabetes Mellitus: Systematic Analysis of Studies From the the Past 20 Years in Turkey
    Ilkova, Hasan
    Damci, Taner
    Siva, Zeynep Osar
    Ozyazar, Mucahit
    Yumuk, Volkan
    Gorpe, Esat Ugur
    Hatipoglu, Esra
    [J]. TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2011, 15 (04) : 77 - 105
  • [45] PAHSAs Reduce Type 1 Diabetes Incidence in Nonobese Diabetic (NOD) Mice through Anti-inflammatory Effects and Direct Protection against Cytokine-Induced Islet Beta-Cell Death
    Syed, Ismail
    Mohan, James F.
    Moraes-Vieria, Pedro M.
    Vijayakumar, Archana
    De Celis, Maria F. Rubin
    Nelson, Andrew T.
    Siegel, Dionicio
    Saghatelian, Alan
    Mathis, Diane J.
    Kahn, Barbara B.
    [J]. DIABETES, 2017, 66 : A87 - A87
  • [46] Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus
    Thabet, Hamdy Khamees
    Abusaif, Moustafa S.
    Imran, Mohd
    Helal, Mohamed Hamdy
    Alaqel, Saleh Ibrahim
    Alshehri, Ahmed
    Mohd, Abida Ash
    Ammar, Yousry A.
    Ragab, Ahmed
    [J]. COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2024, 111
  • [47] A PROSPECTIVE REGISTRY TO IDENTIFY PATIENTS' CHARACTERISTICS ASSOCIATED WITH ACHIEVING TARGET METABOLIC CONTROL AFTER THREE MONTHS TREATMENT WITH INSULIN GLULISINE IN TYPE 1 AND 2 DIABETES MELLITUS PATIENTS PREVIOUSLY UNCONTROLLED ON BASAL INSULIN AND/OR OTHER ANTI-DIABETIC TREATMENT (API REGISTRY)
    Gottesman, I
    Girard, M.
    Shorey, S.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A473 - A474